Yahoo Web Search

Search results

1. • Q1 2024 Imunon Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 5 hours ago

     Let me also thank you for joining us for this, a particularly important call. I want to start by welcoming Stacy Lindborg, your new Chief Executive and President to her first ...

2. • Atria Wealth Solutions Inc. Takes $214,000 Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

     ETF DAILY NEWS· 3 days ago

     Atria Wealth Solutions Inc. acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) in the 4th quarter, according to the company in its most ...

3. • Q1 2024 Legend Biotech Corp Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 11 hours ago

     Ashwani Verma; Director of Americas Equity Research & US Specialty Pharma Analyst; UBS Investment Bank, Research Division Dingding Shi; Equity Analyst; Jefferies ...

4. • Q1 2024 Fortrea Holdings Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 11 hours ago

     Note that I've said our commercial transformation will take a year. As we told you in January, we had a tough start to the quarter, and we hoped we could still deliver on ...

5. • TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated by Analysts at StockNews.com

     ETF DAILY NEWS· 6 days ago

     StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the stock. TherapeuticsMD ...

6. • Q1 2024 International Flavors & Fragrances Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

     I think we are now getting the clarity we need and have taken some decisive steps in the first quarter to help us start to realize more of our potential. We recently rightsized ...

7. • Q1 2024 Halozyme Therapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

     And secondly, our partner Vive initiated another Phase one study for v. eight four five two four one eight four, which is an integrase inhibitor with enhanced the performance of our Wave two ...

8. • Q1 2024 Clarivate PLC Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

     We will deliver tailored solutions directly to our core customers across pharma, biotech and medical technology. While a large component of our R&D spend to target towards ...

9. • Q1 2024 Charles River Laboratories International Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 4 days ago

     Biotechs are beginning to move back into favor in the capital markets and will lead the way while large pharma has consistently adapted to scientific advancements, the regulatory ...

10. • Q1 2024 Mettler-Toledo International Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 3 days ago

      Patrick K. Kaltenbach Thanks, Shawn. Let me start with some comments on our operating businesses, starting with Lab. As Shawn mentioned earlier, excluding the Q4...business ...